Laura J. Parry
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Complement Component 1q Deficiency Impairs Maternal Hemodynamic Adaptations to Pregnancy, Decidual Vascular Remodeling, and Fetal Growth in Mice.
Journal: Journal of the American Heart Association
Published: August 27, 2026
Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes.
Journal: Biochemical pharmacology
Published: May 27, 2024
Relaxin elicits renoprotective actions accompanied by increasing bile acid levels in streptozotocin-induced diabetic mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 11, 2023
Endothelium-dependent relaxation is impaired in Schlager hypertensive (BPH/2J) mice by region-specific mechanisms in conductance and resistance arteries.
Journal: Life sciences
Published: December 08, 2022
The role of angiotensin II and relaxin in vascular adaptation to pregnancy.
Journal: Reproduction (Cambridge, England)
Published: May 06, 2022
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Journal: Cardiovascular research
Published: June 15, 2020
Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Journal: American journal of physiology. Heart and circulatory physiology
Published: March 07, 2020
Ocular Phenotype of Relaxin Gene Knockout (Rln-/-) Mice.
Journal: Current eye research
Published: March 07, 2020
The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice.
Journal: International journal of molecular sciences
Published: December 29, 2019
Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl.
Journal: Antioxidants & redox signaling
Published: November 05, 2019
Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases.
Journal: Current opinion in pharmacology
Published: November 10, 2018
Last Updated: 09/26/2026